When something goes wrong in the brain of people with dementia, often it’s more than one thing. But it can be hard to tease apart multiple brain diseases, especially in the early stages, or even ...
The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...
Researchers say a simple blood test could help flag which older women face a higher risk of dementia long before any symptoms appear. In a new study, published in JAMA Network Open, women with higher ...
Share on Pinterest Could a midlife blood test help detect subtle and early cognitive decline? Alvaro Lavin/Stocksy Some current research has been focusing on how to identify the earliest signs of ...
The blood biomarker p-tau217 has "shown the most promise in detecting Alzheimer's in the brain," researchers of a new study say. Reading time 3 minutes Your blood might someday reveal much about the ...
Share on Pinterest Could a blood test for an Alzheimer’s-related protein help predict disease risk years before symptoms begin? Jovana Milanko/Stocksy Blood-based biomarkers of Alzheimer’s disease can ...
A decades-long study of postmenopausal women shows that a simple blood biomarker may help identify individuals at higher risk of cognitive decline and dementia years before symptoms appear. Study: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results